Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05283148 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sickle Cell Disease (SCD) Bone Pain Study

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion pushed from Jul 31, 2026 to Dec 31, 2027 Show 4 more changesShow less
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Publications: details revised at 1 of 1 entry
    • Study description expanded, about 3 words
  2. Results first posted: Aug 24, 2025v13 Show 4 more changesShow less
    • Primary endpoints: 3 to 7
    • Primary completion date: Dec 22, 2023 to Apr 30, 2024
    • Study completion date: Dec 31, 2026 to Jul 31, 2026
    • Secondary endpoints: 2 to 1
  3. Trial status: Completed to Active, Not Recruiting
    • Study completion date: Dec 22, 2023 to Dec 31, 2026
    v12
  4. Trial status: Active, Not Recruiting to Completed
    • Study completion date changed from estimate of Mar 31, 2024 to Dec 22, 2023
    • Study description expanded, about 2 words
    v11
  5. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 50 to confirmed 53
    • Site details revised
    v10
Show 8 earlier versionsHide 8 earlier versions
  1. Primary completion date: Dec 31, 2023 to Dec 22, 2023v9
  2. Study title revisedv8
  3. Phase: Not specified to Not applicable
    • Study title revised
    • Study arms: 0 to 1
    v7
  4. Re-verified, no change to tracked fieldsv6
  5. Primary completion date: Oct 2023 to Dec 31, 2023v5 Show 6 more changesShow less
    • Study completion date: Apr 2024 to Mar 31, 2024
    • Secondary endpoints: details revised at 2 of 2 entries
    • Site contact updated
    • Collaborators expanded, about 11 words
    • Study description expanded, about 5 words
    • Study title shortened, about 1 word
  6. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Sep 2023 to Oct 2023
    • Study completion date: Nov 2023 to Apr 2024
    • Start date changed from estimate of Sep 2022 to Nov 3, 2022
  7. Start date: Jun 2022 to Sep 2022v3
  8. Start date: Mar 2022 to Jun 2022v2 Show 5 more changesShow less
    • Primary endpoints revised (3)
    • Primary completion date: Aug 2023 to Sep 2023
    • Study completion date: Oct 2023 to Nov 2023
    • Study description expanded, about 9 words
    • Eligibility criteria expanded, about 3 words
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A prospective study to determine how low bone mineral density and/or vertebral compression fractures associate with pain in adults with sickle cell disease
Trial Details
NCT Number NCT05283148
Lead Sponsor University of California, Davis
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), Doris Duke Charitable Foundation
Conditions
(from sponsor)		 Sickle Cell Disease, Sickle Cell Anemia, Low Bone Density, Osteoporosis, Osteopenia, Vertebral Fracture, Vertebral Compression, Osteonecrosis +2 more
Related terms Anemia, Sickle Cell, Bone Diseases, Metabolic, Osteonecrosis, Osteoporosis, Spinal Fractures
Enrollment 53 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov